Spots Global Cancer Trial Database for uterine cancer
Every month we try and update this database with for uterine cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| MR-HIFU for Recurrent Gynaecological Cancer | NCT02714621 | Cervical Cancer Endometrial Can... Uterine Cancer Ovarian Cancer Vaginal Cancer Vulvar Cancer | Magnetic Resona... | 18 Years - | Institute of Cancer Research, United Kingdom | |
| Effect of Anesthetic Agents on Optic Nerve Sheath Diameter | NCT03701529 | Uterus Myoma Uterine Cancer | Sevoflurane Propofol | 18 Years - 65 Years | Hallym University Kangnam Sacred Heart Hospital | |
| A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors | NCT01176500 | Colon Cancer Lung Cancer Cervical Cancer Renal Cell Carc... Uterine Cancer | (18)Fluciclatid... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients | NCT05529303 | Cervix Cancer Uterine Cancer Ovarian Cancer Endometrial Can... Vulva Cancer Grief Femininity | Such as art the... | 18 Years - 65 Years | Afyonkarahisar Health Sciences University | |
| Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients | NCT04038619 | Colitis Diarrhea Malignant Genit... Melanoma Lung Cancer Ovarian Cancer Uterine Cancer Breast Cancer Cervical Cancer | Fecal Microbiot... Loperamide | 18 Years - | M.D. Anderson Cancer Center | |
| Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers | NCT02725489 | Breast Cancer Ovarian Cancer Fallopian Tube ... Primary Periton... Uterine Cancer Cervical Cancer Endometrial Can... | Vigil Durvalumab | 18 Years - | Mary Crowley Medical Research Center | |
| A Retrospective Study on Multiple Classifier Endometrial Cancer | NCT05976113 | Uterine Cancer | Observation onl... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer | NCT00471120 | Uterine Cancer Endometrial Can... | P2x7 assay | 18 Years - | CytoCore, Inc. | |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | NCT03662204 | Breast Cancer Lung Cancer Colorectal Canc... Prostate Cancer Bladder Cancer Uterine Cancer Kidney Cancer Renal Pelvis Ca... Pancreatic Canc... Liver Cancer Stomach Cancer Ovarian Cancer Esophageal Canc... | Blood Sample Co... | 18 Years - | Exact Sciences Corporation | |
| Laser Fluorescence in Cancer Surgical Treatment | NCT03021200 | Esophageal Canc... Gastric Cancer ColoRectal Canc... Prostatic Neopl... Uterine Cancer Head and Neck C... Breast Neoplasm | Green indociani... | 18 Years - | Instituto do Cancer do Estado de São Paulo | |
| Evaluation of Patient Reported Knowledge and Satisfaction Following the Use of an Enhanced Gynecologic Brachytherapy-Specific Educational Video | NCT04363957 | Cervical Cancer Uterine Cancer | Brachytherapy v... Standard Brachy... | 18 Years - | University of California, San Diego | |
| Strength Training Study for Survivors of Breast and Gynecologic Cancer | NCT01709175 | Breast Cancer Gynecologic Can... Ovarian Cancer Uterine Cancer Cervical Cancer | Strength Traini... | 18 Years - | Nova Scotia Health Authority | |
| A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma | NCT03395080 | Endometrial Can... Uterine Cancer Ovarian Cancer Carcinosarcoma | Paclitaxel 300mg DKN-01 600mg DKN-01 | 18 Years - | Leap Therapeutics, Inc. | |
| Effectiveness of an Individualized Symptom Education Program (ISEP) | NCT00275353 | Uterine Cancer Cervical Cancer Vaginal Cancer Vulvar Cancer | Individualized ... | 18 Years - | University of Toronto | |
| Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors | NCT04106492 | Cancer | SQ3370 | 18 Years - | Shasqi, Inc. | |
| AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma | NCT03668340 | Uterine Cancer | AZD1775 | 18 Years - | Dana-Farber Cancer Institute | |
| Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients | NCT03924466 | Metastatic Brea... Locally Advance... Cancer of Pancr... Solid Tumor Wit... Salivary Gland ... Gastric Cancer Endometrial Can... Uterine Cancer Non Small Cell ... Biliary Tract C... Cholangiocarcin... Colorectal Canc... Urothelial Carc... Prostate Cancer | 68GaNOTA-Anti-H... | 18 Years - | Universitair Ziekenhuis Brussel | |
| SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care | NCT04368130 | Ovarian Cancer Fallopian Tube ... Primary Periton... Uterine Cancer Cervical Cancer Gynecologic Can... | SIGNAL | 18 Years - | Dana-Farber Cancer Institute | |
| Strength Training Study for Survivors of Breast and Gynecologic Cancer | NCT01709175 | Breast Cancer Gynecologic Can... Ovarian Cancer Uterine Cancer Cervical Cancer | Strength Traini... | 18 Years - | Nova Scotia Health Authority | |
| A Mind-body Intervention to Improve Body and/or Self Image | NCT02531997 | Breast Cancer Ovarian Cancer Uterine Cancer Cervical Cancer | Hypnotic Relaxa... Progressive Mus... | 21 Years - | University of Michigan | |
| [18F]FES PET/.CT in Uterine Cancer | NCT05916196 | Uterine Cancer | 18F-Fluoroestra... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients | NCT03924466 | Metastatic Brea... Locally Advance... Cancer of Pancr... Solid Tumor Wit... Salivary Gland ... Gastric Cancer Endometrial Can... Uterine Cancer Non Small Cell ... Biliary Tract C... Cholangiocarcin... Colorectal Canc... Urothelial Carc... Prostate Cancer | 68GaNOTA-Anti-H... | 18 Years - | Universitair Ziekenhuis Brussel | |
| Neo-adjuvant Pembrolizumab in dMMR/ POLE-EDM Uterine Cancer Patients: a Feasibility Study | NCT04262089 | Uterine Cancer | Pembrolizumab (... | 18 Years - | University Medical Center Groningen | |
| A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers | NCT03073525 | Advanced Gyneco... Ovarian Cancer Cervical Cancer Uterine Cancer | Vigil Atezolizumab | 18 Years - | Gradalis, Inc. | |
| Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations | NCT04579380 | Uterine Neoplas... Uterine Cervica... Biliary Tract N... Urologic Neopla... Carcinoma, Non-... HER2 Mutations ... | tucatinib trastuzumab fulvestrant | 18 Years - | Seagen Inc. | |
| Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies | NCT03762733 | Breast Cancer Ovarian Cancer Uterine Cancer | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine | NCT05697198 | Lung Cancer Ovarian Cancer Uterine Cancer Colorectal Canc... Stomach Cancer Esophageal Canc... Pancreatic Canc... Melanoma Breast Cancer Head and Neck C... Soft Tissue Sar... Rhabdomyosarcom... Prostate Cancer | OmniSeq Test | 18 Years - | Labcorp Corporation of America Holdings, Inc | |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | NCT03662204 | Breast Cancer Lung Cancer Colorectal Canc... Prostate Cancer Bladder Cancer Uterine Cancer Kidney Cancer Renal Pelvis Ca... Pancreatic Canc... Liver Cancer Stomach Cancer Ovarian Cancer Esophageal Canc... | Blood Sample Co... | 18 Years - | Exact Sciences Corporation | |
| A Study of Nivolumab in Selected Uterine Cancer Patients | NCT03241745 | Uterine Cancer Endometrial Car... Carcinosarcoma Leiomyosarcoma Undifferentiate... High Grade Endo... Clear Cell Carc... | Nivolumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy | NCT00508703 | Uterine Cancer Cervical Cancer Endometrial Can... | Intensity Modul... CT Scan | - | M.D. Anderson Cancer Center | |
| Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation | NCT03285802 | Uterine Cancer | Letrozole Everolimus | 18 Years - | Greater Baltimore Medical Center | |
| Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy | NCT00746018 | Cervical Cancer Ovarian Cancer Uterine Cancer | LigaSure vessel... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer | NCT02458001 | Cervical Cancer Ovarian Cancer Uterine Cancer Vaginal Cancer Vulval Cancer Psychosexual Dy... | SAFFRON stepped... | 18 Years - | University College, London | |
| Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix | NCT01600040 | Uterine Cancer Cervical Cancer | Proton radiatio... | 18 Years - | Massachusetts General Hospital | |
| Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1 | NCT01234012 | Solid Tumor | IMF-001 | 18 Years - | ImmunoFrontier, Inc. | |
| Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. | NCT01492179 | Uterine Myoma Persistent Post... Uterine Cancer | Normal saline Intravenous Lid... Intra-abdominal... | 30 Years - 75 Years | Örebro University, Sweden | |
| Evaluation of Robot-Assisted Surgery in Gynecologic Oncology | NCT00671827 | Gynecologic Can... | Questionnaire | - | M.D. Anderson Cancer Center | |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | NCT03662204 | Breast Cancer Lung Cancer Colorectal Canc... Prostate Cancer Bladder Cancer Uterine Cancer Kidney Cancer Renal Pelvis Ca... Pancreatic Canc... Liver Cancer Stomach Cancer Ovarian Cancer Esophageal Canc... | Blood Sample Co... | 18 Years - | Exact Sciences Corporation | |
| A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers | NCT00231829 | Uterine Cancer | Celecoxib | 18 Years - | Montefiore Medical Center | |
| Insights Into Participating in Studies for Uterine Cancer | NCT05998811 | Uterine Cancer | 18 Years - | Power Life Sciences Inc. | ||
| Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma | NCT00414076 | Leiomyosarcoma Uterine Neoplas... | Letrozole | 18 Years - | M.D. Anderson Cancer Center | |
| Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. | NCT01953107 | Ovarian Cancer Cervical Cancer Uterine Cancer Anemia | Oral Ferrous Fu... Placebo | 18 Years - | Sunnybrook Health Sciences Centre | |
| Neo-adjuvant Pembrolizumab in dMMR/ POLE-EDM Uterine Cancer Patients: a Feasibility Study | NCT04262089 | Uterine Cancer | Pembrolizumab (... | 18 Years - | University Medical Center Groningen | |
| Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus | NCT00614835 | Uterine Leiomyo... Uterine Cancer | Docetaxel plus ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Sentinel Node Biopsy in Endometrial Cancer | NCT04073706 | Endometrial Can... Sentinel Lymph ... Surgery | TH BSO with SNB... TH BSO without ... | 18 Years - | Queensland Centre for Gynaecological Cancer | |
| Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors | NCT00588276 | Cervical Cancer HEENT Cancer Renal Cancer Uterine Cancer CERVIX UTERI NO... RECTUM | 124I-Iodo-Azomy... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase 1 Study of OSI-930 in Cancer Patients | NCT00513851 | Advanced Solid ... | OSI-930 OSI-930 | 18 Years - | Astellas Pharma Inc | |
| Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema | NCT00944944 | Ovarian Cancer Uterine Cancer Vaginal Cancer Lymphedema | limb volume mea... GCLQ lymphedema... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | NCT05864144 | Solid Tumor, Ad... Advanced Solid ... Head and Neck C... Breast Cancer Colon Cancer Pancreatic Canc... Gastric Cancer Esophageal Canc... Prostate Cancer Uterine Cancer Cervix Cancer Ovarian Cancer Kidney Cancer Bladder Cancer Thyroid Cancer Melanoma Sarcoma Advanced Cancer Metastatic Canc... Refractory Canc... Non Small Cell ... | SNS-101 (anti-V... Cemiplimab | 18 Years - | Sensei Biotherapeutics, Inc. | |
| Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer | NCT03583736 | Uterine Cancer | Virtual visit Office visit | 18 Years - | Case Comprehensive Cancer Center | |
| Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy | NCT00508703 | Uterine Cancer Cervical Cancer Endometrial Can... | Intensity Modul... CT Scan | - | M.D. Anderson Cancer Center | |
| Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix | NCT00626561 | Cervical Cancer Uterine Cancer | Bevacizumab Paclitaxel | - | M.D. Anderson Cancer Center | |
| A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors | NCT05949632 | Advanced Solid ... | INCB099280 axitinib | 18 Years - | Incyte Corporation | |
| Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer | NCT01650376 | Stage III Ovari... Stage IV Ovaria... Uterine Cancer | Olaparib Carboplatin Paclitaxel | 18 Years - | Swedish Medical Center | |
| The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery | NCT01284075 | Ovarian Cancer Uterine Cancer | Guided imagery ... White Noise No intervention | 19 Years - | University of Minnesota | |
| Uterine Papillary Serous Cancer (UPSC) Trial | NCT00147680 | Uterine Cancer | Paclitaxel, Car... | 18 Years - | Queensland Centre for Gynaecological Cancer | |
| Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma | NCT00506779 | Uterine Cancer | Imatinib Mesyla... Paclitaxel | - | M.D. Anderson Cancer Center | |
| RAD001 in Recurrent Endometrial Cancer Patients | NCT00087685 | Endometrial Can... | RAD001 | - | M.D. Anderson Cancer Center | |
| Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus | NCT00231842 | Uterine Cancer | Ifosfamide Radiation Thera... Cisplatin | 18 Years - | Montefiore Medical Center | |
| Evaluation of Patient Reported Knowledge and Satisfaction Following the Use of an Enhanced Gynecologic Brachytherapy-Specific Educational Video | NCT04363957 | Cervical Cancer Uterine Cancer | Brachytherapy v... Standard Brachy... | 18 Years - | University of California, San Diego | |
| Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy | NCT01570218 | Breast Cancer Uterine Cancer Ovarian Cancer | Music therapy | 20 Years - 80 Years | Universidade Federal de Goias | |
| Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology | NCT06392997 | Gynecologic Dis... Gynecologic Can... Endometriosis Ovarian Cancer Cyst Ovary Fibroid Cervical Cancer Uterine Cancer | Saliva sample | 18 Years - | ZIWIG | |
| Trial of Maintenance With Niraparib- Uterine Serous Carcinoma | NCT04080284 | Endometrial Can... Papillary Serou... Uterine Serous ... Endometrial Car... Cancer of the E... | Niraparib | 18 Years - | Northwell Health | |
| Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer | NCT03192059 | Cervical Cancer Endometrial Can... Uterine Cancer | Pembrolizumab Radiation Vitamin D Aspirin Lansoprazole Cyclophosphamid... Curcumin | 18 Years - | University Hospital, Ghent | |
| Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers | NCT03604653 | Stomach Cancer Colorectal Canc... Appendiceal Can... Ovarian Cancer Uterine Cancer Cervical Cancer Fallopian Tube ... Primary Periton... | HIPEC Mitomycin c CDDP 50 CDDP 75 Doxorubicin | 18 Years - | Holy Name Medical Center, Inc. | |
| Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer | NCT03694834 | Endometrial Can... Uterine Cancer | Pembrolizumab Hysterectomy | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers | NCT03073525 | Advanced Gyneco... Ovarian Cancer Cervical Cancer Uterine Cancer | Vigil Atezolizumab | 18 Years - | Gradalis, Inc. | |
| Image-Guided Gynecologic Brachytherapy | NCT02993900 | Cervical Cancer Uterine Cancer Vaginal Cancer Vulvar Cancer Bladder Cancer | Image-Guided Br... | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Effect of Hemp-CBD on Patients With CIPN | NCT04398446 | Chemotherapy-in... Colorectal Canc... Colorectal Canc... Breast Cancer Ovarian Cancer Uterine Cancer Pancreatic Canc... | Hemp-based CBD Placebo oral ta... | 21 Years - | Main Line Health | |
| The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer | NCT00444054 | Cancer Breast Cancer Colon Cancer Cervical Cancer Uterine Cancer Ovarian Cancer | Very low carboh... | 21 Years - | Albert Einstein College of Medicine | |
| Assisted Exercise in Obese Endometrial Cancer Patients | NCT01870947 | Stage I Endomet... Uterine Cancer Obesity | Exercise on sta... Health Educatio... Questionnaires Neuroimaging Genetic and Bio... | 18 Years - | Case Comprehensive Cancer Center | |
| Interventions to Decrease Financial Toxicity | NCT05939440 | Cancer, Breast Cancer Colorect... Cancer, Ovarian Cervical Cancer Uterine Cancer Vulvar Cancer | Proactive Cost ... Usual Care | 18 Years - | University of Alabama at Birmingham | |
| AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma | NCT03668340 | Uterine Cancer | AZD1775 | 18 Years - | Dana-Farber Cancer Institute | |
| Pillars4Life Trial | NCT02465892 | Breast Cancer Lung Cancer Esophageal Canc... Colon Cancer Pancreatic Canc... Liver Cancer Renal Cancer Bladder Cancer Prostate Cancer Ovarian Cancer Cervical Cancer Uterine Cancer | Pillars4Life | 18 Years - | Duke University | |
| Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors | NCT04681248 | Esophageal Neop... Adenocarcinoma ... GastroEsophagea... Squamous Cell C... Gastric Adenoca... Endometrial Can... Uterine Cancer Ovarian Cancer Carcinosarcoma Gastric Cancer | DKN-01 | 18 Years - | Leap Therapeutics, Inc. | |
| Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy | NCT00121030 | Gynecological M... Genital Neoplas... Anemia | darbepoetin alf... recombinant hum... | 18 Years - | Amgen | |
| Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus | NCT00614835 | Uterine Leiomyo... Uterine Cancer | Docetaxel plus ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer | NCT03694834 | Endometrial Can... Uterine Cancer | Pembrolizumab Hysterectomy | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | NCT03896958 | Cancer, All Typ... Cancer of Liver Cancer of Stoma... Cancer of Head ... Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Colon Cancer Skin Cancer of Cervi... Cancer, Metasta... Cancer of Laryn... Cancer of Neck Cancer of Lung Cancer of Brain... Cancer of Vulva... Cancer of Pancr... Sarcoma GIST Small-cell Lung... Adenocarcinoma ... Cancer of Prost... Cancer, Advance... Adrenal Cancer Testicular Canc... Uterine Cancer Bronchoalveolar... Cancer Unknown ... Glioblastoma Mu... Oligodendroglio... Breast Cancer Renal Cell Carc... Hepatocellular ... Cholangiocarcin... Squamous Cell C... Transitional Ce... Cancer, Other Cancer, Anal Melanoma Cancer, Bile Du... Cancer, Bladder Cancer Cords Vo... Cancers Cell Ne... Cancer Differen... Cancer, Anaplas... | 1 Month - 99 Years | SpeciCare | ||
| [18F]FES PET/.CT in Uterine Cancer | NCT05916196 | Uterine Cancer | 18F-Fluoroestra... | 18 Years - | Abramson Cancer Center at Penn Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
